| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |